Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Real-world data with pazopanib confirm clinical trial findings in renal cell cancer

Dr Thomas Powles, Dr Victoria Galvis, Dr Marc Matrana , Prof John Wagstaff
Real-world data with pazopanib confirm clinical trial findings in renal cell cancer ( Dr Thomas Powles, Dr Victoria Galvis, Dr Marc Matrana , Prof John Wagstaff )
23 Oct 2013

ecancermedicalscience Editor's Choice: Robotic surgery in oncology

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice: Robotic surgery in oncology ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Oct 2013

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology
European Cancer Congress 2013 - News Roundup ( Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology )
22 Oct 2013

Treating chest lymph nodes in early breast cancer improves survival without Increasing side effects

Dr Philip Poortmans - Institute Verbeeten, Tilburg, The Netherlands
Treating chest lymph nodes in early breast cancer improves survival without Increasing side effects ( Dr Philip Poortmans - Institute Verbeeten, Tilburg, The Netherlands )
18 Oct 2013

Meeting highlights from the 11th iwNHL 2013: Day 2

Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh
Meeting highlights from the 11th iwNHL 2013: Day 2 ( Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh )
15 Oct 2013

Meeting highlights from the 11th iwNHL 2013: Day 1

Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh
Meeting highlights from the 11th iwNHL 2013: Day 1 ( Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh )
15 Oct 2013

European Research Initiative in CLL (ERIC) and iwCLL explained

Dr Emil Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain
European Research Initiative in CLL (ERIC) and iwCLL explained ( Dr Emil Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain )
10 Oct 2013

Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan

Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan ( Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan )
7 Oct 2013

FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA )
7 Oct 2013

Launch of the Institute of Cancer Policy

Prof Richard Sullivan - King's College London, UK
Launch of the Institute of Cancer Policy ( Prof Richard Sullivan - King's College London, UK )
7 Oct 2013

Stem cell therapy for prevention of radiation-induced salivary gland toxicity

Dr Rob Coppes - University of Groningen, Netherlands
Stem cell therapy for prevention of radiation-induced salivary gland toxicity ( Dr Rob Coppes - University of Groningen, Netherlands )
7 Oct 2013

Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma

Dr Michele Maio - University Hospital of Siena, Siena, Italy
Survival analysis of a follow-up phase III study of ipilimumab and dacarbazine in metastatic melanoma ( Dr Michele Maio - University Hospital of Siena, Siena, Italy )
4 Oct 2013